Literature DB >> 22287541

The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics.

Shahram Ghanaati1, Mike Barbeck, Rainer Detsch, Ulrike Deisinger, Ulrike Hilbig, Vera Rausch, Robert Sader, Ronald E Unger, Guenter Ziegler, Charles James Kirkpatrick.   

Abstract

Bone substitute material properties such as granule size, macroporosity, microporosity and shape have been shown to influence the cellular inflammatory response to a bone substitute material. Keeping these parameters constant, the present study analyzed the in vivo tissue reaction to three bone substitute materials (granules) with different chemical compositions (hydroxyapatite (HA), beta-tricalcium phosphate (TCP) and a mixture of both with a HA/TCP ratio of 60/40 wt%). Using a subcutaneous implantation model in Wistar rats for up to 30 days, tissue reactions, including the induction of multinucleated giant cells and the extent of implantation bed vascularization, were assessed using histological and histomorphometrical analyses. The results showed that the chemical composition of the bone substitute material significantly influenced the cellular response. When compared to HA, TCP attracted significantly greater multinucleated giant cell formations within the implantation bed. Furthermore, the vascularization of the implantation bed of TCP was significantly higher than that of HA implantation beds. The biphasic bone substitute group combined the properties of both groups. Within the first 15 days, high giant cell formation and vascularization rates were observed, which were comparable to the TCP-group. However, after 15 days, the tissue reaction, i.e. the extent of multinucleated giant cell formation and vascularization, was comparable to the HA-group. In conclusion, the combination of both compounds HA and TCP may be a useful combination for generating a scaffold for rapid vascularization and integration during the early time points after implantation and for setting up a relatively slow degradation. Both of these factors are necessary for successful bone tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287541     DOI: 10.1088/1748-6041/7/1/015005

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  38 in total

1.  Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration.

Authors:  Vineet Gupta; Dina V Lyne; Marilyn Barragan; Cory J Berkland; Michael S Detamore
Journal:  J Mater Sci Mater Med       Date:  2016-06-07       Impact factor: 3.896

2.  Reconstructing jaw defects with MSCs and PLGA-encapsulated growth factors.

Authors:  Boon Ching Tee; Kashappa Goud H Desai; Kelly S Kennedy; Brittany Sonnichsen; Do-Gyoon Kim; Henry W Fields; Susan R Mallery; Steven P Schwendeman; Zongyang Sun
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 3.  Specialized Histological and Histomorphometrical Analytical Methods for Biocompatibility Testing of Biomaterials for Maxillofacial Surgery in (Pre-) Clinical Studies.

Authors:  Carolin Lindner; Annica PrÖhl; Ole Jung; Mike Barbeck; Manuel Abels; Tom LÖffler; Milijana Batinic
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 4.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

5.  Nanofibrous antibiotic-eluting matrices: Biocompatibility studies in a rat model.

Authors:  Patrícia C Passos; Juliana Moro; Raquel Cristine Silva Barcelos; Higor Z Da Rosa; Luciana T Vey; Marilise Escobar Bürguer; Roberto M Maciel; Cristiane C Danesi; Paul C Edwards; Marco C Bottino; Karla Z Kantorski
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-04-23       Impact factor: 3.368

Review 6.  New Prospects in Nano Phased Co-substituted Hydroxyapatite Enrolled in Polymeric Nanofiber Mats for Bone Tissue Engineering Applications.

Authors:  Kareem E Mosaad; Kamel R Shoueir; Ahmed H Saied; Montasser M Dewidar
Journal:  Ann Biomed Eng       Date:  2021-08-10       Impact factor: 3.934

7.  In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology.

Authors:  Ronald E Unger; Sanja Stojanovic; Laura Besch; Said Alkildani; Romina Schröder; Ole Jung; Caroline Bogram; Oliver Görke; Stevo Najman; Wolfgang Tremel; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

8.  In Vivo Analysis of the Biocompatibility and Bone Healing Capacity of a Novel Bone Grafting Material Combined with Hyaluronic Acid.

Authors:  Annica Pröhl; Milijana Batinic; Said Alkildani; Michael Hahn; Milena Radenkovic; Stevo Najman; Ole Jung; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

Review 9.  Synthetic Injectable Biomaterials for Alveolar Bone Regeneration in Animal and Human Studies.

Authors:  Matej Tomas; Marija Čandrlić; Martina Juzbašić; Zrinka Ivanišević; Nikola Matijević; Aleksandar Včev; Olga Cvijanović Peloza; Marko Matijević; Željka Perić Kačarević
Journal:  Materials (Basel)       Date:  2021-05-26       Impact factor: 3.623

10.  Performance of Nano-Hydroxyapatite/Beta-Tricalcium Phosphate and Xenogenic Hydroxyapatite on Bone Regeneration in Rat Calvarial Defects: Histomorphometric, Immunohistochemical and Ultrastructural Analysis.

Authors:  Igor da Silva Brum; Lucio Frigo; Paulo Goncalo Pinto Dos Santos; Carlos Nelson Elias; Guilherme Aparecido Monteiro Duque da Fonseca; Jorge Jose de Carvalho
Journal:  Int J Nanomedicine       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.